Uptake in the third biennial screening invitation round per subgroup by sociodemographics and other outcomes in percentages with the denominator (n)
| Consistent Screeners | Late Entrants | Dropouts | Consistent Non-Responders | |
|---|---|---|---|---|
| gFOB uptake in the 3rd invitation round | ||||
| Total | 94.53 (29 182) | 78.04 (4937)†*** | 59.82 (4263)†***/‡*** | 14.59 (16 656)†***/‡***/§*** |
| Women | 94.63 (15 863) | 78.17 (2414) | 59.04 (2268) | 13.75 (7773) |
| Men | 94.42 (13 319) | 77.92 (2523) | 60.70 (1995) | 15.32 (8883) |
| IMD 1st quintile | 95.56 (6558)¶ | 79.29 (1096)†† | 62.81 (812)‡‡ | 16.70 (2802)§§ |
| IMD 2nd quintile | 95.31 (6313) | 78.31 (890) | 61.39 (834) | 18.03 (3023) |
| IMD 3rd quintile | 94.67 (6099) | 79.48 (1004) | 62.56 (868) | 14.87 (3101) |
| IMD 4th quintile | 93.86 (5608) | 77.30 (1000) | 58.93 (857) | 13.63 (3486) |
| IMD 5th quintile | 92.62 (4597) | 75.58 (946) | 53.77 (889) | 11.29 (4233) |
| Age 64–65 at 3rd invitation¶¶ | 94.70 (14 895) | 78.36 (2458) | 60.85 (2258) | 15.25 (8878) |
| Age 66–67 at 3rd invitation | 94.57 (12 015) | 77.61 (2032) | 59.10 (1670) | 14.07 (6560) |
| Age 68+ at 3rd invitation | 93.27 (2272) | 78.30 (447) | 56.42 (335) | 12.56 (1218) |
| Multiple gFOB testing | ||||
| % Requiring one test only | 94.67 (27 629) | 93.54 (3871)†** | 92.13 (2568)†***/‡* | 90.66 (2484)†***/‡ |
| % Requiring multiple test kits | 5.33 (27 629) | 6.46 (3871)†** | 7.87 (2568)†***/‡* | 9.34 (2484)†***/‡ |
| % Inadequately screened | 0.16 (27 629) | 0.46 (3871)†*** | 0.70 (2568)†***/‡ | 2.17 (2484)†***/‡***/§*** |
| FOB positivity | ||||
| Total | 1.73 (27 587) | 2.36 (3853)†** | 2.35 (2550)†**/‡ | 3.25 (2430)†***/‡*/§ |
| Follow-up compliance | ||||
| Total | 89.92 (476) | 86.81 (91)† | 80.00 (60)†*/‡ | 79.75 (79)†**/‡/§ |
| Diagnostic outcomes | ||||
| Cancers | 7.01 (428) | 2.53 (79)† | 10.42 (48)†/‡ | 11.11 (63)†/‡*/§ |
| High-risk and intermediate-risk adenomas | 21.03 (428) | 24.05 (79)† | 22.92 (48)†/‡ | 26.98 (63)†/‡/§ |
| Low-risk adenomas | 16.36 (428) | 22.78 (79)† | 12.50 (48)†/‡ | 11.11 (63)†/‡/§ |
| Other abnormal findings | 33.64 (428) | 32.91 (79)† | 18.75 (48)†*/‡ | 30.16 (63)†/‡/§ |
*p<0.05; **p<0.01; *** p<0.001.
†Compared with consistent screeners.
‡Compared with Late Entrants.
§Compared with Dropouts.
¶IMD scores were not available for 7 individuals.
††IMD score was not available for 1 individual.
‡‡IMD scores were not available for 3 individuals.
§§IMD scores were not available for 11 individuals.
¶¶Includes 63-year-olds turning 64 in the same month (n=2).
gFOB, guaiac-based faecal occult blood; IMD, Index of Multiple Deprivation.